Parasutterella excrementihominis Promotes Experimental Colitis and Colitis-Related Colorectal Cancer Through the Induction of Pathogenic NETosis
-
By
-
May 1, 2026
Objective:
To investigate the role of Parasutterella excrementihominis in exacerbating experimental colitis and colitis-associated colorectal cancer through the induction of NETosis, highlighting the significance of NETosis in these conditions.
Key Findings:
- P. excrementihominis is enriched in UC patients and linked to disease activity.
- The bacterium produces metabolites, including succinic acid and 6-hydroxyhexanoic acid, that activate NETosis via specific signaling pathways.
- NETosis exacerbates mucosal damage and promotes chronic inflammation in UC and CAC.
Interpretation:
The study establishes a direct link between P. excrementihominis and the exacerbation of colitis and colorectal cancer through the induction of pathogenic NETosis, suggesting potential therapeutic targets and implications for future research.
Limitations:
- The study primarily uses animal models, which may not fully replicate human disease.
- Further research is needed to explore the clinical implications of targeting P. excrementihominis, including potential biases in sample collection or analysis.
Conclusion:
Targeting P. excrementihominis or its metabolites may provide new therapeutic strategies for managing ulcerative colitis and preventing colitis-associated colorectal cancer, warranting further investigation.
